Peminib
Pemigatinib
- Strength
- 13.5 mg
- Manufacturer
- Ziska Pharma
- Availability
- Available to source
Pemigatinib 13.5 mg — Tablet, 14's Pot
Need assistance?
Our multilingual healthcare support team can help with availability, shipping and ordering.
Chat on WhatsApp
Scan for WeChat
About this medicine
Originator: PEMAZYRE by INCYTE CORP · Manufacturer: Ziska Pharma. Indication & Dosage: Peminib (Pemigatinib), generic PEMAZYRE is a prescription medicine used to treat of adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma (Bile duct cancer) with a fibroblast growth factor receptor 2 (FGFR2) fusion or other rearrangement. Pemigatinib is also used for the treatment of adults with relapsed or refractory myeloid/ lymphoid neoplasms (MLNs) with fibroblast rearrangement. Pemigatinib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as kinase inhibitors. Peminib is manufactured by Ziska Pharmaceuticals Ltd. in Bangladesh. Pemigatinib has to be taken orally with or without food as directed by your doctor. Side Effects: The most common adverse reactions of Pemigatinib are: Weight loss , mouth sores , dry mouth , constipation , changes in taste, dry eyes, loss of appetite, nausea , vomiting , diarrhea , tiredness/weakness, headache, or dry skin. The above information comes from the Internet. Please consult with doctor for medical advice.
Indications
This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.
